{
  "abstract": "The cost effectiveness thresholds used to evaluate whether new medicines can be rolled out on the NHS are set to rise after pressure from the US.",
  "authors": [
    {
      "affiliations": [
        "Kent"
      ],
      "name": "Jacqui Wise"
    }
  ],
  "title": "UK-US pharmaceutical deal: NHS will pay billions more for new drugs",
  "uid": "ad53acae-9ae8-5b54-a058-90d91769cb2b"
}